1. Home
  2. NEUP vs DPRO Comparison

NEUP vs DPRO Comparison

Compare NEUP & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUP
  • DPRO
  • Stock Information
  • Founded
  • NEUP 1996
  • DPRO 1998
  • Country
  • NEUP United States
  • DPRO Canada
  • Employees
  • NEUP N/A
  • DPRO N/A
  • Industry
  • NEUP
  • DPRO Aerospace
  • Sector
  • NEUP
  • DPRO Industrials
  • Exchange
  • NEUP Nasdaq
  • DPRO Nasdaq
  • Market Cap
  • NEUP 12.7M
  • DPRO 10.4M
  • IPO Year
  • NEUP N/A
  • DPRO N/A
  • Fundamental
  • Price
  • NEUP $7.01
  • DPRO $2.77
  • Analyst Decision
  • NEUP Strong Buy
  • DPRO Strong Buy
  • Analyst Count
  • NEUP 1
  • DPRO 2
  • Target Price
  • NEUP $21.00
  • DPRO $5.25
  • AVG Volume (30 Days)
  • NEUP 22.3K
  • DPRO 2.5M
  • Earning Date
  • NEUP 08-15-2025
  • DPRO 08-12-2025
  • Dividend Yield
  • NEUP N/A
  • DPRO N/A
  • EPS Growth
  • NEUP N/A
  • DPRO N/A
  • EPS
  • NEUP 0.00
  • DPRO N/A
  • Revenue
  • NEUP $15,662,715.00
  • DPRO $4,716,450.00
  • Revenue This Year
  • NEUP N/A
  • DPRO $94.01
  • Revenue Next Year
  • NEUP N/A
  • DPRO $95.14
  • P/E Ratio
  • NEUP $4,149.50
  • DPRO N/A
  • Revenue Growth
  • NEUP N/A
  • DPRO 7.90
  • 52 Week Low
  • NEUP $2.90
  • DPRO $1.55
  • 52 Week High
  • NEUP $126.00
  • DPRO $6.09
  • Technical
  • Relative Strength Index (RSI)
  • NEUP N/A
  • DPRO 57.61
  • Support Level
  • NEUP N/A
  • DPRO $2.46
  • Resistance Level
  • NEUP N/A
  • DPRO $3.22
  • Average True Range (ATR)
  • NEUP 0.00
  • DPRO 0.38
  • MACD
  • NEUP 0.00
  • DPRO 0.03
  • Stochastic Oscillator
  • NEUP 0.00
  • DPRO 35.81

About NEUP Neuphoria Therapeutics Inc. Common Stock

Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

Share on Social Networks: